Can a common cancer drug boost success of tear duct surgery?
NCT ID NCT07154121
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study tests whether adding 5-fluorouracil (a drug that prevents scarring) to standard tear duct surgery helps people with small tear sacs and blocked tear ducts. About 100 adults will receive either the drug or a placebo during surgery. The goal is to see if the drug improves tear drainage and reduces the chance of the surgical opening closing up again.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ACQUIRED NASOLACRIMAL DUCT OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Ophthalmic Center
RECRUITINGGuangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.